| HOME >> BIOLOGY >> TECHNOLOGY |
Restricted cash 3,571 3,451
Other assets 423 466
Total assets $ 56,935 $ 67,955
Liabilities and
stockholders' equity
Current liabilities:
Accounts payable and accrued
liabilities $ 3,106 $ 3,551
Current portion of debt 5,046 5,275
Warrants liability 2,403 2,492
Total current liabilities 10,555 11,318
Debt, less current portion 5,097 6,342
Deferred rent 15,596 15,415
Commitments and
contingencies
Stockholders' equity:
Preferred stock, $0.001 par
value; 5,000,000 shares
authorized; no shares issued
and outstanding at March 31,
2008 and December 31, 2007,
respectively - -
Common stock, $0.001 par
value; 75,000,000 shares
authorized; 41,299,598
and 41,168,432 issued and
outstanding at March 31,
2008 and December 31, 2007,
respectively 41 41
Additional paid-in capital 235,101 233,807
Accumulated other
comprehensive income 2 7
Deficit accumulated during
the development stage (209,457) (198,975)
Total stockholders' equity 25,687 34,880
Total liabilities and
stockholders' equity $ 56,935 $ 67,955
FAVRILLE, INC.
(a development stage company)
STATEMENTS OF OPERATIONS
'/>"/>| SOURCE Favrille, Inc. Copyright©2008 PR Newswire. All rights reserved |